223 related articles for article (PubMed ID: 32073142)
41. T cell functions of IL-2-activated tumor-infiltrating lymphocytes from renal cell carcinoma.
Morita T; Salmeron MA; Hayakawa K; Swanson DA; von Eschenbach AC; Itoh K
Reg Immunol; 1992; 4(4):225-35. PubMed ID: 1476875
[TBL] [Abstract][Full Text] [Related]
42. Single-cell transcriptomics reveals a low CD8
Peng YL; Xiong LB; Zhou ZH; Ning K; Li Z; Wu ZS; Deng MH; Wei WS; Wang N; Zou XP; He ZS; Huang JW; Luo JH; Liu JY; Jia N; Cao Y; Han H; Guo SJ; Dong P; Yu CP; Zhou FJ; Zhang ZL
J Immunother Cancer; 2022 Feb; 10(2):. PubMed ID: 35121646
[TBL] [Abstract][Full Text] [Related]
43. Infiltrating T cells promote renal cell carcinoma (RCC) progression via altering the estrogen receptor β-DAB2IP signals.
Yeh CR; Ou ZY; Xiao GQ; Guancial E; Yeh S
Oncotarget; 2015 Dec; 6(42):44346-59. PubMed ID: 26587829
[TBL] [Abstract][Full Text] [Related]
44. Peripheral T cell receptor repertoire features predict durable responses to anti-PD-1 inhibitor monotherapy in advanced renal cell carcinoma.
Kato T; Kiyotani K; Tomiyama E; Koh Y; Matsushita M; Hayashi Y; Nakano K; Ishizuya Y; Wang C; Hatano K; Kawashima A; Ujike T; Fujita K; Nonomura N; Uemura M
Oncoimmunology; 2021 Jan; 10(1):1862948. PubMed ID: 33537170
[TBL] [Abstract][Full Text] [Related]
45. NK and T cells with a cytotoxic/migratory phenotype accumulate in peritumoral tissue of patients with clear cell renal carcinoma.
Strizova Z; Taborska P; Stakheev D; Partlová S; Havlova K; Vesely S; Bartunkova J; Smrz D
Urol Oncol; 2019 Jul; 37(7):503-509. PubMed ID: 31030972
[TBL] [Abstract][Full Text] [Related]
46. Questionable relevance of gamma delta T lymphocytes in renal cell carcinoma.
Inman BA; Frigola X; Harris KJ; Kuntz SM; Lohse CM; Leibovich BC; Kwon ED
J Immunol; 2008 Mar; 180(5):3578-84. PubMed ID: 18292585
[TBL] [Abstract][Full Text] [Related]
47. Transcriptomic signatures related to the obesity paradox in patients with clear cell renal cell carcinoma: a cohort study.
Sanchez A; Furberg H; Kuo F; Vuong L; Ged Y; Patil S; Ostrovnaya I; Petruzella S; Reising A; Patel P; Mano R; Coleman J; Russo P; Liu CH; Dannenberg AJ; Chan TA; Motzer R; Voss MH; Hakimi AA
Lancet Oncol; 2020 Feb; 21(2):283-293. PubMed ID: 31870811
[TBL] [Abstract][Full Text] [Related]
48. T cells from hemophilia A subjects recognize the same HLA-restricted FVIII epitope with a narrow TCR repertoire.
Ettinger RA; Paz P; James EA; Gunasekera D; Aswad F; Thompson AR; Matthews DC; Pratt KP
Blood; 2016 Oct; 128(16):2043-2054. PubMed ID: 27471234
[TBL] [Abstract][Full Text] [Related]
49. Characterization of fresh (uncultured) tumour-infiltrating lymphocytes (TIL) and TIL-derived T cell lines from patients with renal cell carcinoma.
Mitropoulos D; Kooi S; Rodriguez-Villanueva J; Platsoucas CD
Clin Exp Immunol; 1994 Aug; 97(2):321-7. PubMed ID: 8050183
[TBL] [Abstract][Full Text] [Related]
50. TCR Convergence in Individuals Treated With Immune Checkpoint Inhibition for Cancer.
Looney TJ; Topacio-Hall D; Lowman G; Conroy J; Morrison C; Oh D; Fong L; Zhang L
Front Immunol; 2019; 10():2985. PubMed ID: 31993050
[TBL] [Abstract][Full Text] [Related]
51. Phenotype analysis of tumour-infiltrating lymphocytes and lymphocytes in peripheral blood in patients with renal carcinoma.
Kopecký O; Lukesová S; Vroblová V; Vokurková D; Morávek P; Safránek H; Hlávková D; Soucek P
Acta Medica (Hradec Kralove); 2007; 50(3):207-12. PubMed ID: 18254275
[TBL] [Abstract][Full Text] [Related]
52. Interleukin 10-expressing B cells inhibit tumor-infiltrating T cell function and correlate with T cell Tim-3 expression in renal cell carcinoma.
Cai C; Zhang J; Li M; Wu ZJ; Song KH; Zhan TW; Wang LH; Sun YH
Tumour Biol; 2016 Jun; 37(6):8209-18. PubMed ID: 26715281
[TBL] [Abstract][Full Text] [Related]
53. Minimal changes in the systemic immune response after nephrectomy of localized renal masses.
Wald G; Barnes KT; Bing MT; Kresowik TP; Tomanek-Chalkley A; Kucaba TA; Griffith TS; Brown JA; Norian LA
Urol Oncol; 2014 Jul; 32(5):589-600. PubMed ID: 24768357
[TBL] [Abstract][Full Text] [Related]
54. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
55. Features of increased malignancy in eosinophilic clear cell renal cell carcinoma.
Nilsson H; Lindgren D; Axelson H; Brueffer C; Saal LH; Lundgren J; Johansson ME
J Pathol; 2020 Dec; 252(4):384-397. PubMed ID: 32815150
[TBL] [Abstract][Full Text] [Related]
56. Abundant CD8+ tumor infiltrating lymphocytes and beta-2-microglobulin are associated with better outcome and response to interleukin-2 therapy in advanced stage clear cell renal cell carcinoma.
Davis D; Tretiakova MS; Kizzar C; Woltjer R; Krajbich V; Tykodi SS; Lanciault C; Andeen NK
Ann Diagn Pathol; 2020 Aug; 47():151537. PubMed ID: 32454441
[TBL] [Abstract][Full Text] [Related]
57. T cell receptor repertoire profiling predicts the prognosis of HBV-associated hepatocellular carcinoma.
Lin KR; Deng FW; Jin YB; Chen XP; Pan YM; Cui JH; You ZX; Chen HW; Luo W
Cancer Med; 2018 Aug; 7(8):3755-3762. PubMed ID: 29947152
[TBL] [Abstract][Full Text] [Related]
58. Increased expression of activation markers in renal cell carcinoma infiltrating lymphocytes.
Shabtai M; Ye H; Frischer Z; Martin J; Waltzer WC; Malinowski K
J Urol; 2002 Nov; 168(5):2216-9. PubMed ID: 12394762
[TBL] [Abstract][Full Text] [Related]
59. Prognostic significance and immune correlates of CD73 expression in renal cell carcinoma.
Tripathi A; Lin E; Xie W; Flaifel A; Steinharter JA; Stern Gatof EN; Bouchard G; Fleischer JH; Martinez-Chanza N; Gray C; Mantia C; Thompson L; Wei XX; Giannakis M; McGregor BA; Choueiri TK; Agarwal N; McDermott DF; Signoretti S; Harshman LC
J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33177176
[TBL] [Abstract][Full Text] [Related]
60. DAB2IP Plays Important Clinical Significance and Correlates With Immune Infiltration in Renal Cell Carcinoma.
Cao H; Zhang J; Wang W
Technol Cancer Res Treat; 2020; 19():1533033820936682. PubMed ID: 32583730
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
